Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Meyerson

Showing results (181-190 of 387) with videos related to

Pageof 39
Sort By:
Cancer Discovery|June 5, 2014
EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencingJoshua M Francis, Cheng-Zhong Zhang, Cecile L Maire, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier caseBirgit Knoechel, Ami Bhatt, Li Pan, et al.
Gut|April 1, 2021
Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinomaJin Zhou, Zhong Wu, Zhouwei Zhang, et al.
Neuro-Oncology|January 25, 2023
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volumeElisa Aquilanti, Lauren Kageler, Jacqueline Watson, et al.
Nature Biotechnology|May 1, 2012
Absolute quantification of somatic DNA alterations in human cancerScott L Carter, Kristian Cibulskis, Elena Helman, et al.
Cancer Research|September 26, 2013
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerizationJeonghee Cho, Liang Chen, Naveen Sangji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancerChang-Qi Zhu, Keyue Ding, Dan Strumpf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumorVeit J Scheble, Martin Braun, Rameen Beroukhim, et al.
Cancer Discovery|May 16, 2012
Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancersHihu Wing Cheung, Jinyan Du, Jesse S Boehm, et al.
Lung Cancer (Amsterdam, Netherlands)|February 21, 2012
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencingDaniela S Basseres, Francesco D'Alò, Beow Y Yeap, et al.
Pageof 39

Showing results (181-190 of 387) with videos related to

Sort By:
Pageof 39
Cancer Discovery|June 5, 2014
EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencingJoshua M Francis, Cheng-Zhong Zhang, Cecile L Maire, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier caseBirgit Knoechel, Ami Bhatt, Li Pan, et al.
Gut|April 1, 2021
Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinomaJin Zhou, Zhong Wu, Zhouwei Zhang, et al.
Neuro-Oncology|January 25, 2023
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volumeElisa Aquilanti, Lauren Kageler, Jacqueline Watson, et al.
Nature Biotechnology|May 1, 2012
Absolute quantification of somatic DNA alterations in human cancerScott L Carter, Kristian Cibulskis, Elena Helman, et al.
Cancer Research|September 26, 2013
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerizationJeonghee Cho, Liang Chen, Naveen Sangji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancerChang-Qi Zhu, Keyue Ding, Dan Strumpf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumorVeit J Scheble, Martin Braun, Rameen Beroukhim, et al.
Cancer Discovery|May 16, 2012
Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancersHihu Wing Cheung, Jinyan Du, Jesse S Boehm, et al.
Lung Cancer (Amsterdam, Netherlands)|February 21, 2012
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencingDaniela S Basseres, Francesco D'Alò, Beow Y Yeap, et al.
Pageof 39